SPL 0.00% 10.5¢ starpharma holdings limited

Ann: VivaGel phase 3 study results , page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,184 Posts.
    lightbulb Created with Sketch. 26
    Well people hate it when anyone contradicts their deeply held belief. I speak on the strength of my professional experience in pharma research. I have met Jackey Fairley the CEO many years back. While she is a sharp lady the fact remains that BV like any other bacterial -itis is eminently treatable with the right regimen of antibacterials, so you dont need a fancy dendrimer for that. Secondly there is little known about what is special about dendrimers that other organic molecules can't do. Check it out -how many other groups are working on dendrimers for pharmaceuticals around the world? If they were that hot you would expect many research groups hot in pursuit wouldnt you?

    Feel free if you want to buy more. Do your own research and make your own decisions. What I state is just for consideration.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $43.90M
Open High Low Value Volume
10.5¢ 11.5¢ 10.0¢ $110.6K 1.006M

Buyers (Bids)

No. Vol. Price($)
1 83046 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 30000 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.